Telangana DCA seizes ‘Vitency Capsules’ manufactured under food license
Telangana Drugs Control Officials have seized ‘Vitency Capsules’ being manufactured and sold under the guise of 'food products/nutraceuticals' at Pet Basheerabad, Quthbullapur, in the outskirts of the city, an official said on Sunday.
Hyderabad: Telangana Drugs Control Officials have seized ‘Vitency Capsules’ being manufactured and sold under the guise of ‘food products/nutraceuticals’ at Pet Basheerabad, Quthbullapur, in the outskirts of the city, an official said on Sunday.
Similar cases of ‘drugs’ being manufactured under a ‘food licence’ were previously detected by the DCA officials in November 2023 and last month. Those were declared as ‘spurious’ by the Drugs Control Laboratory, Hyderabad, as the content of the active ingredient was found to be ‘NIL’ (i.e., zero drug) in the said products, DCA Director General V B Kamalasan Reddy said in a release here.
Based on credible information, the officials raided the premises of Sri Bluten Pharmacy located at Pet Basheerabad recently and detected the product ‘Vitency Capsules’, which was falsely manufactured under a ‘food licence (FSSAI licence)’ and falsely claimed as a food product/nutraceutical.
The capsules were found to be manufactured at Knox Life Sciences, Village Gullarwala, District Solan, Himachal Pradesh and were being illegally marketed by Axenic Healthcare, Malakpet, Hyderabad, as a food product/nutraceutical.
The product ‘Vitency Capsules’ claims on the label that it contains vitamins in quantities falling within the therapeutic dose range.
According to Schedule-V of Drugs Rules, the product is considered a ‘drug’ used to treat vitamin deficiencies as per the Drugs and Cosmetics Act, the release said.
The product ‘Vitency Capsules’ must be manufactured only under a ‘drug license’ issued under the Drugs and Cosmetics Act, adhering strictly to the ‘Good Manufacturing Practices’ (GMP) outlined in Schedule-M of the Drugs Rules.
Additionally, it must meet the quality standards prescribed in the ‘Schedule-V of Drugs Rules and the ‘Indian Pharmacopoeia’ (IP) as mandated, said the release.
Manufacturing and selling ‘drugs’ without a valid ‘drug license’ is punishable under the Drugs and Cosmetics Act, with imprisonment for up to five years, the DG warned.
